HSP72 is an early biomarker to detect cisplatin and acetaminophen nephrotoxicity

References

• Arany, I. and Safirstein, R.L., 2003. Cisplatin nephrotoxicity. Seminars in nephrology, 23, 460–464.
   PubMed Web of Science ®Google Scholar
• Bagshaw, S.M., 2010. Acute kidney injury: diagnosis and classification of AKI: AKIN or RIFLE? Nature reviews nephrology, 6, 71–73.
   PubMed Web of Science ®Google Scholar
• Barrera-Chimal, J., et al., 2011. Hsp72 is an early and sensitive biomarker to detect acute kidney injury. EMBO molecular medicine, 3, 5–20.
   PubMed Web of Science ®Google Scholar
• Beck, F.X., Neuhofer, W., and Muller, E., 2000. Molecular chaperones in the kidney: distribution, putative roles, and regulation. American journal of physiology – Renal physiology, 279, F203–FF15.
   PubMed Web of Science ®Google Scholar
• Blieden, M., et al., 2014. A perspective on the epidemiology of acetaminophen exposure and toxicity in the United States. Expert review of clinical pharmacology, 7, 341–348.
   PubMed Web of Science ®Google Scholar
• Chawla, L.S., et al., 2011. The severity of acute kidney injury predicts progression to chronic kidney disease. Kidney international, 79, 1361–1369.
   PubMed Web of Science ®Google Scholar
• Chen, Y.G., et al., 2015. Risk of acute kidney injury and long-term outcome in patients with acetaminophen intoxication: a nationwide population-based retrospective cohort study. Medicine (Baltimore), 94, e2040.
   PubMed Web of Science ®Google Scholar
• Coca, S.G. and Parikh, C.R., 2008. Urinary biomarkers for acute kidney injury: perspectives on translation. Clinical journal of the American Society of nephrology, 3, 481–490.
   PubMed Web of Science ®Google Scholar
• Dekkers, I.A., et al., 2013. Long-term nephrotoxicity in adult survivors of childhood cancer. Clinical journal of the American Society of nephrology, 8, 922–929.
   PubMed Web of Science ®Google Scholar
• Demirbag, S., et al., 2010. Effects of medical ozone therapy on acetaminophen-induced nephrotoxicity in rats. Renal failure, 32, 493–497.
   PubMed Web of Science ®Google Scholar
• Dogukan, A., et al., 2011. A tomato lycopene complex protects the kidney from cisplatin-induced injury via affecting oxidative stress as well as Bax, Bcl-2, and HSPs expression. Nutrition and cancer, 63, 427–434.
   PubMed Web of Science ®Google Scholar
• Ferguson, M.A., Vaidya, V.S., and Bonventre, J.V., 2008. Biomarkers of nephrotoxic acute kidney injury. Toxicology, 245, 182–193.
   PubMed Web of Science ®Google Scholar
• Galus, M., et al., 2013. Chronic, low concentration exposure to pharmaceuticals impacts multiple organ systems in zebrafish. Aquatic toxicology, 132–133, 200–211.
   PubMed Web of Science ®Google Scholar
• Kanki, M., et al., 2014. Identification of urinary miRNA biomarkers for detecting cisplatin-induced proximal tubular injury in rats. Toxicology, 324, 158–168.
   PubMed Web of Science ®Google Scholar
• Kos, F.T., et al., 2013. Evaluation of renal function using the level of neutrophil gelatinase-associated lipocalin is not predictive of nephrotoxicity associated with cisplatin-based chemotherapy. Asian Pacific journal of cancer prevention, 14, 1111–1114.
   PubMedGoogle Scholar
• Lewington, A.J., Cerda, J., and Mehta, R.L., 2013. Raising awareness of acute kidney injury: a global perspective of a silent killer. Kidney international, 84, 457–467.
   PubMed Web of Science ®Google Scholar
• Mazer, M. and Perrone, J., 2008. Acetaminophen-induced nephrotoxicity: pathophysiology, clinical manifestations, and management. Journal of medical toxicology, 4, 2–6.
   PubMedGoogle Scholar
• Milner, C.M. and Campbell, R.D., 1990. Structure and expression of the three MHC-linked HSP70 genes. Immunogenetics, 32, 242–251.
   PubMed Web of Science ®Google Scholar
• Mishra, J., et al., 2004. Neutrophil gelatinase-associated lipocalin: a novel early urinary biomarker for cisplatin nephrotoxicity. American journal of nephrology, 24, 307–315.
   PubMed Web of Science ®Google Scholar
• Mour, G., et al., 2005. Acute renal dysfunction in acetaminophen poisoning. Renal failure, 27, 381–383.
   PubMed Web of Science ®Google Scholar
• Ortega-Trejo, J.A., et al., 2015. Heat shock protein 72 (Hsp72) specific induction and temporal stability in urine samples as a reliable biomarker of acute kidney injury (AKI). Biomarkers, 20, 453–459.
   PubMed Web of Science ®Google Scholar
• Ozkok, A. and Edelstein, C.L., 2014. Pathophysiology of cisplatin-induced acute kidney injury. Biomed research international, 2014, 967826.
   PubMed Web of Science ®Google Scholar
• Parikh, C.R., et al., 2006. Urinary IL-18 is an early predictive biomarker of acute kidney injury after cardiac surgery. Kidney international, 70, 199–203.
   PubMed Web of Science ®Google Scholar
• Pavkovic, M., Riefke, B., and Ellinger-Ziegelbauer, H., 2014. Urinary microRNA profiling for identification of biomarkers after cisplatin-induced kidney injury. Toxicology, 324, 147–157.
   PubMed Web of Science ®Google Scholar
• Prescott, L.F., 1983. Paracetamol overdosage. Pharmacological considerations and clinical management. Drugs, 25, 290–314.
   PubMed Web of Science ®Google Scholar
• Ralib, A.M., et al., 2012. Test characteristics of urinary biomarkers depend on quantitation method in acute kidney injury. Journal of the American Society of nephrology, 23, 322–333.
   PubMed Web of Science ®Google Scholar
• Saibil, H., 2013. Chaperone machines for protein folding, unfolding and disaggregation. Nature reviews molecular cell biology, 14, 630–642.
   PubMed Web of Science ®Google Scholar
• Sanchez-Gonzalez, P.D., et al., 2011. An integrative view of the pathophysiological events leading to cisplatin nephrotoxicity. Critical reviews in toxicology, 41, 803–821.
   PubMed Web of Science ®Google Scholar
• Shahbazi, F., et al., 2015. Urine ratio of neutrophil gelatinase-associated lipocalin to creatinine as a marker for early detection of cisplatin-associated nephrotoxicity. Iranian journal of kidney diseases, 9, 306–310.
   PubMed Web of Science ®Google Scholar
• Shinke, H., et al., 2015. Urinary kidney injury molecule-1 and monocyte chemotactic protein-1 are noninvasive biomarkers of cisplatin-induced nephrotoxicity in lung cancer patients. Cancer chemotherapy and pharmacology, 76, 989–996.
   PubMed Web of Science ®Google Scholar
• Sreedharan, R. and van Why, S.K., 2016. Heat shock proteins in the kidney. Pediatric nephrology, 31, 1561–1570.
   PubMed Web of Science ®Google Scholar
• Tuzcu, M., et al., 2010. Protective role of zinc picolinate on cisplatin-induced nephrotoxicity in rats. Journal of renal nutrition, 20, 398–407.
   PubMed Web of Science ®Google Scholar
• Waikar, S.S., Sabbisetti, V.S., and Bonventre, J.V., 2010. Normalization of urinary biomarkers to creatinine during changes in glomerular filtration rate. Kidney international, 78, 486–494.
   PubMed Web of Science ®Google Scholar